CEA and CA 15.3 serum concentrations in patients with primary... | Download Table
The CA 15-3 test and breast cancer: What it is and results
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
![PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4744f482e3401b93bffb69ba515294512d87cb8d/2-Table1-1.png "PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar")
PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Concentrations of CA 15-3, CEA and HER2 in patients with distant... | Download Scientific Diagram
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology
:max_bytes(150000):strip_icc()/breast-cancer-tumor-markers-and-tumor-marker-tests-4301102-30358af146c64584b345c51499c0d70c.png "Breast Cancer Tumor-Marker Tests")
Breast Cancer Tumor-Marker Tests
Plasma levels of tested cytokines and CA 15-3 in patients with breast... | Download Table
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Relationship between tumor markers CEA and CA 15-3 and recurrence breast cancer | Semantic Scholar
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells - ScienceDirect
M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1β | Scientific Reports
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
